Jane Street Group, LLC Chemo Centryx, Inc. Put Options Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

Put Options

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q1 2022 May 17, 2022	BUY	$22.22 - $39.12 $697,708 - $1.23 Million	31,400 Added 25.2%	156,000 $3.91 Million
Q4 2021 Feb 15, 2022	SELL	$18.38 - $40.5 $3.86 Million - $8.5 Million	-209,800 Reduced 62.74%	124,600 $4.54 Million
Q3 2021 Nov 16, 2021	SELL	$13.18 - $19.83 $2.99 Million - $4.51 Million	-227,200 Reduced 40.46%	334,400 $5.72 Million
Q2 2021 Aug 16, 2021	BUY	$9.59 - $50.88 $4.49 Million - $23.8 Million	468,400 Added 502.58%	561,600 $7.52 Million
Q3 2020 Nov 17, 2020	BUY	$46.35 - $61.69 $2.74 Million - $3.65 Million	59,100 Added 173.31%	93,200 $5.11 Million
Q2 2020 Aug 17, 2020	BUY	$38.58 - $65.07 $848,760 - $1.43 Million	22,000 Added 181.82%	34,100 $1.96 Million
Q1 2020 May 15, 2020	BUY	$32.73 - $50.78 $396,032 - $614,438	12,100 New	12,100 $486,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.